Research Article | Open Access
Volume 2021 - 1 | Article ID 200 | http://dx.doi.org/10.51521/IRJCPT.2021.1211
Academic Editor: John Bose
M. LAVANYA1*, D. SUMA PRIYANKA1, P. THARUNIKA DIVYA1, T.V.S.S VATHSALYA1, DR. SK. SALMA2
1Pharm. D, Ratnam
Institute of Pharmacy, Nellore, Andhra Pradesh, India
2Department of Pharmacy practice, Ratnam Institute of Pharmacy, Nellore, Andhra Pradesh, India
Corresponding Author: M. Lavanya, Ratnam Institute of Pharmacy, Nellore, Andhra Pradesh, India. Lavanyamodiboyina1995@gmail.com.
Citation: M. Lavanya, D. Suma Priyanka, P. Tharunika Divya, T.V.S.S Vathsalya, Dr. SK. Salma (2021). Prevalence of Diabetes Mellitus, Hypertension, Obesity in Hypothyroidism Patients: A Cross Sectional Study. Int Res J Clin Stud Pharm Trends, 1(2);1-7.
Copyright: © 2021, M. Lavanya, D. Suma Priyanka, P. Tharunika Divya, T.V.S.S Vatsalya, Dr. Sk. Salma (2021). This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
ABSTRACT:
Hypothyroidism is a condition in which the thyroid gland does not operate properly. It can manifest as an overt state of myxedema, end-organ consequences, and multisystem failure, or as a subclinical illness characterized by normal thyroxine and triiodothyronine levels and modestly raised serum thyrotropin levels. Hypothyroidism has been linked to T2DM, obesity, and hypertension, increasing the risk of hypothyroidism in patients with T2DM and/or hypertension, as well as worsening of diabetes and hypertension-related co-morbidities. This study aimed to estimate the Prevalence of Diabetes mellitus, Hypertension, Obesity in Hypothyroidism patients. A Cross sectional study was carried out. This study reveals that prevalence of hypothyroidism is advancing with age and frequency of prevalence was higher in women than men. According to our study the most prominent age group lies between 35-50yrs. As per our study, obesity has higher percentage of prevalence to hypothyroidism than Diabetes and HTN. This study suggests that Calcium channel blockers with Levothyroxine, biguanides with Levothyroxine are more effective against Hypothyroidism with co-morbidities. Based on 3 follow ups, obesity has no significant changes in TSH levels when compared to hypertension and diabetes, thus obesity has higher risk. More research is needed to identify which adverse health events occur after long term levothyroxine therapy.
KEYWORDS:
Hypothyroidism,
Hypertension, Diabetes, Obesity, Levothyroxine